Functional comparison of bone marrow-derived liver stem cells: selection strategy for cell-based therapy

Area of Science:

• Hepatology and Regenerative Medicine
• Cell Biology
• Biochemistry

Background:

• Bone marrow-derived liver progenitor cells (LPCs) are crucial for liver regeneration.
• Distinct LPC subpopulations exist, but functional comparisons are limited.
• Understanding functional differences is key for therapeutic applications.

Purpose of the Study:

• To compare the liver function of two distinct LPC subpopulations: beta(2)-microglobulin (beta(2)m)-negative/Thy-1-positive cells and panned non-adherent fraction cells.
• To evaluate growth characteristics, metabolic capacity, and gene expression under various culture conditions.
• To identify the optimal LPC subpopulation for cell-based liver disease therapies.

Main Methods:

• Isolation and culture of two distinct LPC subpopulations.
• Culturing cells under varying conditions: hepatocyte growth factor doses, cell densities, and media.
• Assessing growth kinetics, albumin production, and ammonia metabolism.
• Analyzing liver regeneration-associated gene expression.

Main Results:

• Both LPC subpopulations produced albumin and metabolized ammonia to urea.
• Beta(2)m-negative/Thy-1-positive cells demonstrated significantly higher efficiency in ammonia metabolism and superior albumin production compared to panned cells.
• Optimal culture conditions were identified for enhancing LPC function.

Conclusions:

• The beta(2)m-negative/Thy-1-positive LPC subpopulation exhibits superior liver-specific functions.
• This subpopulation holds significant potential for developing cell-based therapies for liver diseases.
• Further research into optimizing these cells could advance regenerative medicine for liver disorders.